, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014. Heifetz A, Schertler GF, Seifert R, Tate CG, Sexton PM, Gurevich VV, Fourmy D, Cherezov V, Marshall FH, Storer RI, Moraes I, Tikhonova IG, Tautermann CS, Hunt P, Ceska T, Hodgson S, Bodkin MJ, Singh S, Law RJ, Biggin PC (2015) Naunyn Schmiedebergs Arch Pharmacol 388(8): 883-903
    › Primary publication · 25772061 (PubMed) · PMC4495723 (PubMed Central)
  2. Development of an MRI biomarker sensitive to tetrameric visual arrestin 1 and its reduction via light-evoked translocation in vivo. Berkowitz BA, Gorgis J, Patel A, Baameur F, Gurevich VV, Craft CM, Kefalov VJ, Roberts R (2015) FASEB J 29(2): 554-64
    › Primary publication · 25351983 (PubMed) · PMC4314227 (PubMed Central)
  3. C-terminal threonines and serines play distinct roles in the desensitization of rhodopsin, a G protein-coupled receptor. Azevedo AW, Doan T, Moaven H, Sokal I, Baameur F, Vishnivetskiy SA, Homan KT, Tesmer JJ, Gurevich VV, Chen J, Rieke F (2015) Elife
    › Primary publication · 25910054 (PubMed) · PMC4438306 (PubMed Central)
  4. Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Kang Y, Zhou XE, Gao X, He Y, Liu W, Ishchenko A, Barty A, White TA, Yefanov O, Han GW, Xu Q, de Waal PW, Ke J, Tan MH, Zhang C, Moeller A, West GM, Pascal BD, Van Eps N, Caro LN, Vishnivetskiy SA, Lee RJ, Suino-Powell KM, Gu X, Pal K, Ma J, Zhi X, Boutet S, Williams GJ, Messerschmidt M, Gati C, Zatsepin NA, Wang D, James D, Basu S, Roy-Chowdhury S, Conrad CE, Coe J, Liu H, Lisova S, Kupitz C, Grotjohann I, Fromme R, Jiang Y, Tan M, Yang H, Li J, Wang M, Zheng Z, Li D, Howe N, Zhao Y, Standfuss J, Diederichs K, Dong Y, Potter CS, Carragher B, Caffrey M, Jiang H, Chapman HN, Spence JC, Fromme P, Weierstall U, Ernst OP, Katritch V, Gurevich VV, Griffin PR, Hubbell WL, Stevens RC, Cherezov V, Melcher K, Xu HE (2015) Nature 523(7562): 561-7
    › Primary publication · 26200343 (PubMed) · PMC4521999 (PubMed Central)
  5. Beyond traditional pharmacology: new tools and approaches. Gurevich EV, Gurevich VV (2015) Br J Pharmacol 172(13): 3229-41
    › Primary publication · 25572005 (PubMed) · PMC4500362 (PubMed Central)
  6. Arrestins regulate cell spreading and motility via focal adhesion dynamics. Cleghorn WM, Branch KM, Kook S, Arnette C, Bulus N, Zent R, Kaverina I, Gurevich EV, Weaver AM, Gurevich VV (2015) Mol Biol Cell 26(4): 622-35
    › Primary publication · 25540425 (PubMed) · PMC4325834 (PubMed Central)
  7. Arrestins: Critical Players in Trafficking of Many GPCRs. Gurevich VV, Gurevich EV (2015) Prog Mol Biol Transl Sci : 1-14
    › Primary publication · 26055052 (PubMed) · PMC5841159 (PubMed Central)
  8. Arrestin-3-Dependent Activation of c-Jun N-Terminal Kinases (JNKs). Zhan X, Kook S, Kaoud TS, Dalby KN, Gurevich EV, Gurevich VV (2015) Curr Protoc Pharmacol : 2.12.1-2.12.26
    › Primary publication · 25737158 (PubMed) · PMC4361079 (PubMed Central)
  9. Analyzing the roles of multi-functional proteins in cells: The case of arrestins and GRKs. Gurevich VV, Gurevich EV (2015) Crit Rev Biochem Mol Biol 50(5): 440-52
    › Primary publication · 26453028 (PubMed) · PMC4852696 (PubMed Central)
  10. Therapeutic potential of small molecules and engineered proteins. Gurevich EV, Gurevich VV (2014) Handb Exp Pharmacol : 1-12
    › Primary publication · 24292822 (PubMed) · PMC4513659 (PubMed Central)